Deere & Company’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,769
Closed -$297K 1122
2015
Q4
$297K Sell
1,769
-2,836
-62% -$436K 0.02% 717
2015
Q3
$651K Buy
4,605
+1,855
+67% +$416K 0.04% 441
2015
Q2
$613K Buy
2,750
+1,640
+148% +$288K 0.03% 548
2015
Q1
$184K Sell
1,110
-476
-30% -$77.3K 0.01% 918
2014
Q4
$188K Sell
1,586
-824
-34% -$86.1K 0.01% 912
2014
Q3
$201K Hold
2,410
0.01% 879
2014
Q2
$223K Hold
2,410
0.01% 814
2014
Q1
$218K Buy
+2,410
New +$269K 0.01% 796

Other funds holding NVAX

Deere & Company's NVAX Position: Q1 2016 in Review

Deere & Company sold out of Novavax (NVAX) in Q1 2016, closing a stake of 1,769 shares — an estimated $297K sold.

Deere & Company first reported a position in NVAX in Q1 2014 and held it in 8 quarters. The position peaked at $651K in Q3 2015. 175 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • Deere & Company reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 1,769 Novavax shares in Q1 2016, an estimated $297K.
  • Deere & Company first reported a position in Novavax in Q1 2014 and held it in 8 quarters.
  • Deere & Company's Novavax position peaked at $651K in Q3 2015.
  • 175 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.